Click for best price
Radiopharmaceutical Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical Therapy. This report contains market size and forecasts of Radiopharmaceutical Therapy in global, including the following market information:
Global Radiopharmaceutical Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Radiopharmaceutical Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Actinium-225 Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Radiopharmaceutical Therapy include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Radiopharmaceutical Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radiopharmaceutical Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Radiopharmaceutical Therapy Market Segment Percentages, by Type, 2022 (%)
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Global Radiopharmaceutical Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Radiopharmaceutical Therapy Market Segment Percentages, by Application, 2022 (%)
Oncology
Cardiology
Other
Global Radiopharmaceutical Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Radiopharmaceutical Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radiopharmaceutical Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Radiopharmaceutical Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Outline of Major Chapters:
Chapter 1: Introduces the definition of Radiopharmaceutical Therapy, market overview.
Chapter 2: Global Radiopharmaceutical Therapy market size in revenue.
Chapter 3: Detailed analysis of Radiopharmaceutical Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radiopharmaceutical Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Radiopharmaceutical Therapy Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
106 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceutical Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceutical Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radiopharmaceutical Therapy Overall Market Size
2.1 Global Radiopharmaceutical Therapy Market Size: 2022 VS 2030
2.2 Global Radiopharmaceutical Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Radiopharmaceutical Therapy Players in Global Market
3.2 Top Global Radiopharmaceutical Therapy Companies Ranked by Revenue
3.3 Global Radiopharmaceutical Therapy Revenue by Companies
3.4 Top 3 and Top 5 Radiopharmaceutical Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Radiopharmaceutical Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radiopharmaceutical Therapy Players in Global Market
3.6.1 List of Global Tier 1 Radiopharmaceutical Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Radiopharmaceutical Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Radiopharmaceutical Therapy Market Size Markets, 2022 & 2030
4.1.2 Actinium-225
4.1.3 Lutetium-177
4.1.4 Radium-223
4.1.5 Holmium-166
4.1.6 Other
4.2 By Type - Global Radiopharmaceutical Therapy Revenue & Forecasts
4.2.1 By Type - Global Radiopharmaceutical Therapy Revenue, 2018-2023
4.2.2 By Type - Global Radiopharmaceutical Therapy Revenue, 2024-2030
4.2.3 By Type - Global Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radiopharmaceutical Therapy Market Size, 2022 & 2030
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Other
5.2 By Application - Global Radiopharmaceutical Therapy Revenue & Forecasts
5.2.1 By Application - Global Radiopharmaceutical Therapy Revenue, 2018-2023
5.2.2 By Application - Global Radiopharmaceutical Therapy Revenue, 2024-2030
5.2.3 By Application - Global Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Radiopharmaceutical Therapy Market Size, 2022 & 2030
6.2 By Region - Global Radiopharmaceutical Therapy Revenue & Forecasts
6.2.1 By Region - Global Radiopharmaceutical Therapy Revenue, 2018-2023
6.2.2 By Region - Global Radiopharmaceutical Therapy Revenue, 2024-2030
6.2.3 By Region - Global Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Radiopharmaceutical Therapy Revenue, 2018-2030
6.3.2 US Radiopharmaceutical Therapy Market Size, 2018-2030
6.3.3 Canada Radiopharmaceutical Therapy Market Size, 2018-2030
6.3.4 Mexico Radiopharmaceutical Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Radiopharmaceutical Therapy Revenue, 2018-2030
6.4.2 Germany Radiopharmaceutical Therapy Market Size, 2018-2030
6.4.3 France Radiopharmaceutical Therapy Market Size, 2018-2030
6.4.4 U.K. Radiopharmaceutical Therapy Market Size, 2018-2030
6.4.5 Italy Radiopharmaceutical Therapy Market Size, 2018-2030
6.4.6 Russia Radiopharmaceutical Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Radiopharmaceutical Therapy Market Size, 2018-2030
6.4.8 Benelux Radiopharmaceutical Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Radiopharmaceutical Therapy Revenue, 2018-2030
6.5.2 China Radiopharmaceutical Therapy Market Size, 2018-2030
6.5.3 Japan Radiopharmaceutical Therapy Market Size, 2018-2030
6.5.4 South Korea Radiopharmaceutical Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Radiopharmaceutical Therapy Market Size, 2018-2030
6.5.6 India Radiopharmaceutical Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Radiopharmaceutical Therapy Revenue, 2018-2030
6.6.2 Brazil Radiopharmaceutical Therapy Market Size, 2018-2030
6.6.3 Argentina Radiopharmaceutical Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radiopharmaceutical Therapy Revenue, 2018-2030
6.7.2 Turkey Radiopharmaceutical Therapy Market Size, 2018-2030
6.7.3 Israel Radiopharmaceutical Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Radiopharmaceutical Therapy Market Size, 2018-2030
6.7.5 UAE Radiopharmaceutical Therapy Market Size, 2018-2030
7 Radiopharmaceutical Therapy Companies Profiles
7.1 Bracco Imaging
7.1.1 Bracco Imaging Company Summary
7.1.2 Bracco Imaging Business Overview
7.1.3 Bracco Imaging Radiopharmaceutical Therapy Major Product Offerings
7.1.4 Bracco Imaging Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.1.5 Bracco Imaging Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Radiopharmaceutical Therapy Major Product Offerings
7.2.4 Bayer Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Mallinckrodt
7.3.1 Mallinckrodt Company Summary
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Radiopharmaceutical Therapy Major Product Offerings
7.3.4 Mallinckrodt Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.3.5 Mallinckrodt Key News & Latest Developments
7.4 Nordion
7.4.1 Nordion Company Summary
7.4.2 Nordion Business Overview
7.4.3 Nordion Radiopharmaceutical Therapy Major Product Offerings
7.4.4 Nordion Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.4.5 Nordion Key News & Latest Developments
7.5 Triad Isotopes
7.5.1 Triad Isotopes Company Summary
7.5.2 Triad Isotopes Business Overview
7.5.3 Triad Isotopes Radiopharmaceutical Therapy Major Product Offerings
7.5.4 Triad Isotopes Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.5.5 Triad Isotopes Key News & Latest Developments
7.6 Lantheus
7.6.1 Lantheus Company Summary
7.6.2 Lantheus Business Overview
7.6.3 Lantheus Radiopharmaceutical Therapy Major Product Offerings
7.6.4 Lantheus Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.6.5 Lantheus Key News & Latest Developments
7.7 IBA Group
7.7.1 IBA Group Company Summary
7.7.2 IBA Group Business Overview
7.7.3 IBA Group Radiopharmaceutical Therapy Major Product Offerings
7.7.4 IBA Group Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.7.5 IBA Group Key News & Latest Developments
7.8 GE Healthcare
7.8.1 GE Healthcare Company Summary
7.8.2 GE Healthcare Business Overview
7.8.3 GE Healthcare Radiopharmaceutical Therapy Major Product Offerings
7.8.4 GE Healthcare Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.8.5 GE Healthcare Key News & Latest Developments
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Company Summary
7.9.2 China Isotope & Radiation Business Overview
7.9.3 China Isotope & Radiation Radiopharmaceutical Therapy Major Product Offerings
7.9.4 China Isotope & Radiation Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.9.5 China Isotope & Radiation Key News & Latest Developments
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Company Summary
7.10.2 Jubilant Pharma Business Overview
7.10.3 Jubilant Pharma Radiopharmaceutical Therapy Major Product Offerings
7.10.4 Jubilant Pharma Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.10.5 Jubilant Pharma Key News & Latest Developments
7.11 Eli Lilly
7.11.1 Eli Lilly Company Summary
7.11.2 Eli Lilly Business Overview
7.11.3 Eli Lilly Radiopharmaceutical Therapy Major Product Offerings
7.11.4 Eli Lilly Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.11.5 Eli Lilly Key News & Latest Developments
7.12 Advanced Accelerator Applications
7.12.1 Advanced Accelerator Applications Company Summary
7.12.2 Advanced Accelerator Applications Business Overview
7.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Major Product Offerings
7.12.4 Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.12.5 Advanced Accelerator Applications Key News & Latest Developments
7.13 SIEMENS
7.13.1 SIEMENS Company Summary
7.13.2 SIEMENS Business Overview
7.13.3 SIEMENS Radiopharmaceutical Therapy Major Product Offerings
7.13.4 SIEMENS Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.13.5 SIEMENS Key News & Latest Developments
7.14 Dongcheng
7.14.1 Dongcheng Company Summary
7.14.2 Dongcheng Business Overview
7.14.3 Dongcheng Radiopharmaceutical Therapy Major Product Offerings
7.14.4 Dongcheng Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.14.5 Dongcheng Key News & Latest Developments
7.15 Navidea
7.15.1 Navidea Company Summary
7.15.2 Navidea Business Overview
7.15.3 Navidea Radiopharmaceutical Therapy Major Product Offerings
7.15.4 Navidea Radiopharmaceutical Therapy Revenue in Global Market (2018-2023)
7.15.5 Navidea Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Radiopharmaceutical Therapy Market Opportunities & Trends in Global Market
Table 2. Radiopharmaceutical Therapy Market Drivers in Global Market
Table 3. Radiopharmaceutical Therapy Market Restraints in Global Market
Table 4. Key Players of Radiopharmaceutical Therapy in Global Market
Table 5. Top Radiopharmaceutical Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Radiopharmaceutical Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Radiopharmaceutical Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Radiopharmaceutical Therapy Product Type
Table 9. List of Global Tier 1 Radiopharmaceutical Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radiopharmaceutical Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Radiopharmaceutical Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Radiopharmaceutical Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Radiopharmaceutical Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Radiopharmaceutical Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Radiopharmaceutical Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Radiopharmaceutical Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Radiopharmaceutical Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Radiopharmaceutical Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Radiopharmaceutical Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Radiopharmaceutical Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Radiopharmaceutical Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Radiopharmaceutical Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Radiopharmaceutical Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Radiopharmaceutical Therapy Revenue, (US$, Mn), 2024-2030
Table 30. Bracco Imaging Company Summary
Table 31. Bracco Imaging Radiopharmaceutical Therapy Product Offerings
Table 32. Bracco Imaging Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Bracco Imaging Key News & Latest Developments
Table 34. Bayer Company Summary
Table 35. Bayer Radiopharmaceutical Therapy Product Offerings
Table 36. Bayer Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Key News & Latest Developments
Table 38. Mallinckrodt Company Summary
Table 39. Mallinckrodt Radiopharmaceutical Therapy Product Offerings
Table 40. Mallinckrodt Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Mallinckrodt Key News & Latest Developments
Table 42. Nordion Company Summary
Table 43. Nordion Radiopharmaceutical Therapy Product Offerings
Table 44. Nordion Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Nordion Key News & Latest Developments
Table 46. Triad Isotopes Company Summary
Table 47. Triad Isotopes Radiopharmaceutical Therapy Product Offerings
Table 48. Triad Isotopes Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Triad Isotopes Key News & Latest Developments
Table 50. Lantheus Company Summary
Table 51. Lantheus Radiopharmaceutical Therapy Product Offerings
Table 52. Lantheus Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Lantheus Key News & Latest Developments
Table 54. IBA Group Company Summary
Table 55. IBA Group Radiopharmaceutical Therapy Product Offerings
Table 56. IBA Group Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. IBA Group Key News & Latest Developments
Table 58. GE Healthcare Company Summary
Table 59. GE Healthcare Radiopharmaceutical Therapy Product Offerings
Table 60. GE Healthcare Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. GE Healthcare Key News & Latest Developments
Table 62. China Isotope & Radiation Company Summary
Table 63. China Isotope & Radiation Radiopharmaceutical Therapy Product Offerings
Table 64. China Isotope & Radiation Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. China Isotope & Radiation Key News & Latest Developments
Table 66. Jubilant Pharma Company Summary
Table 67. Jubilant Pharma Radiopharmaceutical Therapy Product Offerings
Table 68. Jubilant Pharma Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Jubilant Pharma Key News & Latest Developments
Table 70. Eli Lilly Company Summary
Table 71. Eli Lilly Radiopharmaceutical Therapy Product Offerings
Table 72. Eli Lilly Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Eli Lilly Key News & Latest Developments
Table 74. Advanced Accelerator Applications Company Summary
Table 75. Advanced Accelerator Applications Radiopharmaceutical Therapy Product Offerings
Table 76. Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Advanced Accelerator Applications Key News & Latest Developments
Table 78. SIEMENS Company Summary
Table 79. SIEMENS Radiopharmaceutical Therapy Product Offerings
Table 80. SIEMENS Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. SIEMENS Key News & Latest Developments
Table 82. Dongcheng Company Summary
Table 83. Dongcheng Radiopharmaceutical Therapy Product Offerings
Table 84. Dongcheng Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Dongcheng Key News & Latest Developments
Table 86. Navidea Company Summary
Table 87. Navidea Radiopharmaceutical Therapy Product Offerings
Table 88. Navidea Radiopharmaceutical Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Navidea Key News & Latest Developments
List of Figures
Figure 1. Radiopharmaceutical Therapy Segment by Type in 2022
Figure 2. Radiopharmaceutical Therapy Segment by Application in 2022
Figure 3. Global Radiopharmaceutical Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Radiopharmaceutical Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Radiopharmaceutical Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Radiopharmaceutical Therapy Revenue in 2022
Figure 8. By Type - Global Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Radiopharmaceutical Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Radiopharmaceutical Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
Figure 16. US Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
Figure 28. China Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Radiopharmaceutical Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Radiopharmaceutical Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. Bracco Imaging Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mallinckrodt Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Nordion Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Triad Isotopes Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Lantheus Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. IBA Group Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. GE Healthcare Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. China Isotope & Radiation Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Jubilant Pharma Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Eli Lilly Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. SIEMENS Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Dongcheng Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Navidea Radiopharmaceutical Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
